Trial Profile
A Phase 1 Randomized, Double-Blind, Vehicle-Controlled, Multiple-Dose Study of the Safety, Absorption and Systemic Pharmacokinetics of ME1111 Topical Agent Applied to All Toenails of Adult Moderate to Severe Onychomycosis Patients for 28 Days
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Dec 2014
Price :
$35
*
At a glance
- Drugs ME 1111 (Primary)
- Indications Onychomycosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Meiji Seika Pharma
- 17 Jun 2014 New trial record